And this is far from the first time that a promising drug candidate for Alzheimers has failed to cross the finish line in late-stage clinical trials
The label treats 2.5 mg as the starting dose before 5 mg
As we mentioned at the beginning of this article, GSH binds these free radicals and relieves oxidative stress not just on the mitochondria but on the rest of the cell
Commit to consistent use for at least three months before judging results
Min & Kim, Diabetes Metab J, 2022 Dramatically Improves Metabolic Health Tirzepatide leads to significant improvements in blood sugar, insulin sensitivity, and cholesterol, powerfully addressing the metabolic dysfunction that drives aging
And while I dont think animal studies are worthless, theyre preliminary